I've just come across a patent application on the WIPO website, which has been titled "Pharmaceutical Formulation". The patent from page 7 onwards uses the TPM Propofol invention as an example.
So does this also mean that the active ingredients listed on page 2 could contain both the additional Terumo formulations and injectables?
https://patentscope.wipo.int/search/docservicepdf_pct/id00000038223178/PAMPH/WO2017096427.pdf
Terumo and Propofol Injectable, page-2
-
- There are more pages in this discussion • 129 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add POH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.0¢ |
Change
0.000(0.00%) |
Mkt cap ! n/a | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| POH (ASX) Chart |
Day chart unavailable
